Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > I had no idea …..
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(285)
•••
Comment by beenthereon Dec 18, 2024 8:43pm
81 Views
Post# 36369391

RE:RE:RE:I had no idea …..

RE:RE:RE:I had no idea …..

How the snow and wind treating you?
I admired you Cape Bretoners!
Everynite when I watch CTV  weather I think of you poor guys!
Even with no storm you could be looking at  90 k plus winds!

I do agree with what you are saying but,..

.. always that " but " ......management as in "poor" sorry "worse than poor" was for sure a big part of the issue!

Looking back it sure looks like a super scam!

And regardless what you think I think jd was a big part of it! 

( All in my opinion I have no proof that was the case)
( legal stuff to keep jd happy)

IMO jd sucked me in big time and if I bought BTI stock it was because of his influence!

$250 000 LOSS over 10 years plus!

Biggest loss in 40 years plus investing!   Destroyed me!

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities